Use of maintenance medications in patients with insufficiently controlled obstructive airway disease (OAD): the Belgian control survey

W. Vincken, P. Bartsch (Brussels, Liege, Belgium)

Source: Annual Congress 2002 - Asthma - Therapy and management -2
Session: Asthma - Therapy and management -2
Session type: Thematic Poster Session
Number: 411
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Vincken, P. Bartsch (Brussels, Liege, Belgium). Use of maintenance medications in patients with insufficiently controlled obstructive airway disease (OAD): the Belgian control survey. Eur Respir J 2002; 20: Suppl. 38, 411

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Characteristics of patients with insufficiently controlled obstructive airway disease (OAD): the Belgian control survey
Source: Eur Respir J 2002; 20: Suppl. 38, 48s
Year: 2002

Withdrawal of inhaled corticosteroids in people with chronic obstructive pulmonary disease (COPD) in primary care – a randomised controlled trial
Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD
Year: 2005


Inhaler therapy in obstructive airways disease (OAD): prescription, compliance and technique
Source: Eur Respir J 2006; 28: Suppl. 50, 57s
Year: 2006

Effects of an eHealth intervention promoting correct use of medication in patients with asthma and chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Remote monitoring of respiratory patients
Year: 2021



How frequent is bronchodilator reversibility in patients with stable asthma bronchiale and chronic obstructive lung disease (COPD) receiving maintenance therapy?
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012


Osteoporosis risk assessment in elderly male patients with COPD who use inhaled corticosteroids
Source: Annual Congress 2006 - COPD therapy
Year: 2006


The influence of type of inhalation device on adherence of COPD patients to inhaled medication
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013


A qualitative study of self-reported compliance with medication and lifestyle in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2003; 22: Suppl. 45, 428s
Year: 2003

Drug prescribing and burden of asthma and chronic obstructive pulmonary disease (COPD): a study from Italian general practitioners
Source: Eur Respir J 2005; 26: Suppl. 49, 672s
Year: 2005

The influence of inhalation device for bronchodilators on the results of therapy in primary care patients with bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008


A 2 year programme to improve inhaler technique for adult patients with asthma and chronic obstructive pulmonary disease in a Welsh university health board
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Audit of inhaled corticosteroid prescription in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: management
Year: 2010


Are current treatment recommendations suited to elderly patients with asthma or COPD?
Source: Eur Respir Mon; 2009: 43: 267–285
Year: 2009

Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


Inhaled maintenance therapy and risk of first or subsequent emergency department visit/hospitalization in patients with COPD
Source: Annual Congress 2006 - COPD therapy
Year: 2006


Once-daily QVA149 improves dyspnoea, lung function and reduces rescue medication use in symptomatic patients with COPD using LAMA as prior medication: The BLAZE study
Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases
Year: 2014


Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD
Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers
Year: 2006


The efficacy of formoterol in patients with chronic obstructive pulmonary disease (COPD) is not influenced by concomitant corticosteroid use
Source: Eur Respir J 2001; 18: Suppl. 33, 515s
Year: 2001

Practical aspects of inhaler therapy in frail elderly patients
Source: Eur Respir Mon; 2009: 43: 256–266
Year: 2009